echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > How to mend a broken heart?

    How to mend a broken heart?

    • Last Update: 2022-02-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Image: Isogenic iPS cell-derived cardiomyocytes have reduced contractility and impaired desmosome assembly



    How can a broken heart be repaired? Gene replacement therapy may work in some cases, say researchers from Japan


    In a Stem Cell study published in January, researchers from Osaka University reported that heart cells from a patient with a hereditary heart disease called arrhythmogenic cardiomyopathy contracted incorrectly in the lab, which replaced the mutated gene responsible for repairing the defect.


    Arrhythmogenic cardiomyopathy occurs due to mutations in genes associated with desmosomes, which form "welds" between cells that help them communicate and move in a coordinated fashion


    "Previous studies in cardiomyocytes have shown that mutations in PKP2 play a pathological role in arrhythmic cardiomyopathy," said Hiroyuki Inoue, lead author of the study


    To study how cells from a patient behaved in the lab, the researchers first took a blood sample from a young patient with arrhythmic cardiomyopathy, induced some of the blood cells to become stem cells, and then differentiated those stem cells into the heart cells


    "Due to the lack of thrombophilin 2, cells with two mutated copies of PKP2 clearly showed reduced contractility and impaired desmosome assembly," explained senior author Shuichiro Higo


    Replacing mutated PKP2 with an intact gene copy repaired defects in cell shrinkage and desmosome assembly, which the researchers could observe using time-lapse methods and fluorescently labeled desmosomes


    "These findings demonstrate that our cardiomyocyte line recapitulates the pathology of arrhythmogenic cardiomyopathy and provides a fast and convenient platform for developing gene therapies for this disease," Higo said


    Given that PKP2 is the most common gene associated with arrhythmic cardiomyopathy, and that PKP2 mutations can lead to severe disease, new treatments may help stop the disease from progressing



    article title

    Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.